IAMA Therapeutics
Startup
Italian clinical-stage biopharmaceutical company based in Genoa developing innovative treatments for neurological and psychiatric disorders through selective NKCC1 inhibition targeting epilepsy, autism, and neurodevelopmental conditions.
Featured
Explore featured content from IAMA Therapeutics below
Article
Event
Call/Tender
Collaboration
Asset
View All
View less
Products and services
Explore products and services of IAMA Therapeutics below
Product
Service
View All
View less
Research Projects
Explore research projects of IAMA Therapeutics below
No research projects available yet.
No research projects available yet.
View All
View less
Job Opportunities
No open job positions at the moment.